{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:23:19Z","timestamp":1786980199446,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Luzhou science and technology plan projects","award":["2022-JYJ- 118"],"award-info":[{"award-number":["2022-JYJ- 118"]}]},{"name":"major science and technology project in Gansu Province","award":["23ZDFA014"],"award-info":[{"award-number":["23ZDFA014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06258-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:56:17Z","timestamp":1752141377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The radiological response of patients with advanced bone metastases to lutetium-177-labeled DOTA-ibandronic acid assessed by metabolic tumor volume"],"prefix":"10.1007","volume":"151","author":[{"given":"Juan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"6258_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2967\/jnumed.112.111476","volume":"54","author":"DL Bailey","year":"2013","unstructured":"Bailey DL, Willowson KP (2013) An evidence-based review of quantitative SPECT imaging and potential clinical applications. J Nucl Med 54:83\u201389. https:\/\/doi.org\/10.2967\/jnumed.112.111476","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"6258_CR2","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1007\/s00259-013-2542-4","volume":"41","author":"DL Bailey","year":"2014","unstructured":"Bailey DL, Willowson KP (2014) Quantitative SPECT\/CT: SPECT joins PET as a quantitative imaging modality. Eur J Nucl Med Mol Imaging 41(Suppl 1):S17\u201325. https:\/\/doi.org\/10.1007\/s00259-013-2542-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6258_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/cbr.2007.374","volume":"23","author":"S Chakraborty","year":"2008","unstructured":"Chakraborty S, Das T, Banerjee S et al (2008) 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis. Cancer Biother Radiopharm 23:202\u2013213. https:\/\/doi.org\/10.1089\/cbr.2007.374","journal-title":"Cancer Biother Radiopharm"},{"key":"6258_CR4","doi-asserted-by":"publisher","unstructured":"Chardin D, Paquet M, Schiappa R et al (2020) Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study. J Immunother Cancer 8. https:\/\/doi.org\/10.1136\/jitc-2020-000645","DOI":"10.1136\/jitc-2020-000645"},{"key":"6258_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.semnuclmed.2014.07.004","volume":"45","author":"D Davila","year":"2015","unstructured":"Davila D, Antoniou A, Chaudhry MA (2015) Evaluation of osseous metastasis in bone scintigraphy. Semin Nucl Med 45:3\u201315. https:\/\/doi.org\/10.1053\/j.semnuclmed.2014.07.004","journal-title":"Semin Nucl Med"},{"key":"6258_CR6","doi-asserted-by":"publisher","first-page":"1364311","DOI":"10.3389\/fonc.2024.1364311","volume":"14","author":"J Deng","year":"2024","unstructured":"Deng J, Yang J, Wang Y et al (2024) Comparison of the relative diagnostic performance of (68)Ga-DOTA-IBA and (18)F-NaF for the detection of bone metastasis. Front Oncol 14:1364311. https:\/\/doi.org\/10.3389\/fonc.2024.1364311","journal-title":"Front Oncol"},{"key":"6258_CR7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.2967\/jnumed.120.255851","volume":"62","author":"R Fern\u00e1ndez","year":"2021","unstructured":"Fern\u00e1ndez R, Eppard E, Lehnert W et al (2021) Evaluation of safety and dosimetry of (177)Lu-DOTA-ZOL for therapy of bone metastases. J Nucl Med 62:1126\u20131132. https:\/\/doi.org\/10.2967\/jnumed.120.255851","journal-title":"J Nucl Med"},{"key":"6258_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.clgc.2018.04.002","volume":"16","author":"G Isensee","year":"2018","unstructured":"Isensee G, P\u00e9port\u00e9 A, M\u00fcller J et al (2018) Is there a flare phenomenon on bone scintigraphy in men with advanced prostate Cancer treated with Radium-223? Clin Genitourin Cancer 16:349\u2013354. https:\/\/doi.org\/10.1016\/j.clgc.2018.04.002","journal-title":"Clin Genitourin Cancer"},{"key":"6258_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40644-022-00476-0","volume":"22","author":"S Jemaa","year":"2022","unstructured":"Jemaa S, Paulson JN, Hutchings M et al (2022) Full automation of total metabolic tumor volume from FDG-PET\/CT in DLBCL for baseline risk assessments. Cancer Imaging 22:39. https:\/\/doi.org\/10.1186\/s40644-022-00476-0","journal-title":"Cancer Imaging"},{"key":"6258_CR10","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1073\/pnas.0601643103","volume":"103","author":"KL Kavanagh","year":"2006","unstructured":"Kavanagh KL, Guo K, Dunford JE et al (2006) The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci USA 103:7829\u20137834. https:\/\/doi.org\/10.1073\/pnas.0601643103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6258_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13550-024-01094-6","volume":"14","author":"H Li","year":"2024","unstructured":"Li H, Pei W, Yang X et al (2024) Biodistribution and dosimetry of (177)Lu-DOTA-IBA for therapy of bone metastases. EJNMMI Res 14:30. https:\/\/doi.org\/10.1186\/s13550-024-01094-6","journal-title":"EJNMMI Res"},{"key":"6258_CR12","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1038\/s41598-025-97920-5","volume":"15","author":"L Li","year":"2025","unstructured":"Li L, Chen L, Yang J et al (2025) Comparison of (18)F-FDG and (68)Ga-DOTA-IBA in detecting bone metastases: a lesion-basis study. Sci Rep 15:12766. https:\/\/doi.org\/10.1038\/s41598-025-97920-5","journal-title":"Sci Rep"},{"key":"6258_CR13","first-page":"953","volume":"44","author":"K Liepe","year":"2003","unstructured":"Liepe K, Hliscs R, Kropp J et al (2003) Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. J Nucl Med 44:953\u2013960","journal-title":"J Nucl Med"},{"key":"6258_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/rpd\/ncu237","volume":"163","author":"Y Parlak","year":"2015","unstructured":"Parlak Y, Gumuser G, Sayit E (2015) Samarium-153 therapy for prostate cancer: the evaluation of urine activity, staff exposure and dose rate from patients. Radiat Prot Dosimetry 163:468\u2013472. https:\/\/doi.org\/10.1093\/rpd\/ncu237","journal-title":"Radiat Prot Dosimetry"},{"key":"6258_CR15","doi-asserted-by":"publisher","unstructured":"Pfannkuchen N, Meckel M, Bergmann R et al (2017) Novel radiolabeled bisphosphonates for PET diagnosis and endoradiotherapy of bone metastases. Pharmaceuticals (Basel) 10. https:\/\/doi.org\/10.3390\/ph10020045","DOI":"10.3390\/ph10020045"},{"key":"6258_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/rlu.0000000000004634","volume":"48","author":"L Qiu","year":"2023","unstructured":"Qiu L, Wang Y, Liu H et al (2023) Safety and efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a novel theranostic radiopharmaceutical for bone metastases: a phase 0\/I study. Clin Nucl Med 48:489\u2013496. https:\/\/doi.org\/10.1097\/rlu.0000000000004634","journal-title":"Clin Nucl Med"},{"key":"6258_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/1471-0528.12543","volume":"121","author":"SH Shim","year":"2014","unstructured":"Shim SH, Kim DY, Lee DY et al (2014) Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET\/CT, predict the recurrence of endometrial cancer. BJOG 121:1097\u20131106 discussion 1106. https:\/\/doi.org\/10.1111\/1471-0528.12543","journal-title":"BJOG"},{"key":"6258_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.acra.2016.01.001","volume":"23","author":"Y Sun","year":"2016","unstructured":"Sun Y, Lu P, Yu L (2016) The volume-metabolic combined parameters from (18)F-FDG PET\/CT May help predict the outcomes of cervical carcinoma. Acad Radiol 23:605\u2013610. https:\/\/doi.org\/10.1016\/j.acra.2016.01.001","journal-title":"Acad Radiol"},{"key":"6258_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ejrad.2016.01.002","volume":"85","author":"D Tamandl","year":"2016","unstructured":"Tamandl D, Ta J, Schmid R et al (2016) Prognostic value of volumetric PET parameters in unresectable and metastatic esophageal cancer. Eur J Radiol 85:540\u2013545. https:\/\/doi.org\/10.1016\/j.ejrad.2016.01.002","journal-title":"Eur J Radiol"},{"key":"6258_CR20","doi-asserted-by":"publisher","first-page":"1027792","DOI":"10.3389\/fonc.2022.1027792","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang Q, Chen Z et al (2022) Preparation, biological characterization and preliminary human imaging studies of (68)Ga-DOTA-IBA. Front Oncol 12:1027792. https:\/\/doi.org\/10.3389\/fonc.2022.1027792","journal-title":"Front Oncol"},{"key":"6258_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/rlu.0000000000005573","volume":"50","author":"T Xu","year":"2025","unstructured":"Xu T, Wang Y, Liu G et al (2025) Efficacy and safety of 177Lu-DOTA-IBA in tumor bone metastasis treatment: a prospective clinical trial. Clin Nucl Med 50:119\u2013124. https:\/\/doi.org\/10.1097\/rlu.0000000000005573","journal-title":"Clin Nucl Med"},{"key":"6258_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/rlu.0000000000004757","volume":"48","author":"J Yang","year":"2023","unstructured":"Yang J, Deng J, Fan D et al (2023) Biodistribution and internal dosimetry of 68 Ga-DOTA-IBA PET imaging for patients with bone metastases. Clin Nucl Med 48:847\u2013852. https:\/\/doi.org\/10.1097\/rlu.0000000000004757","journal-title":"Clin Nucl Med"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06258-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06258-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06258-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T16:38:54Z","timestamp":1755189534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06258-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["6258"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06258-y","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Affiliated Hospital of Southwest Medical University Review Board approved this study, and all patients received oral and written information on the routine tests performed in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"210"}}